Llopis, M
Hu X, Fujimoto J, Ying L, Reuben A, Chen R, Chow CW, Canales JR, Sun W, Hu J, Parra Cuentas ER, Behrens C, Wu CJ, Swisher SG , Zhang J, Heymach J, Hong WK, Wistuba II, Futreal PA, Su D, Zhang J
As IGF-1R mAbs are readily available for human use, these observations warrant further study into potentially harnessing these drugs to target at least some manifestations of aging
PubMed This article is for educational and research purposes only
message us to confirm current price before ordering
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for two distinct indications: treatment of type 2 diabetes mellitus (Mounjaro) and chronic weight management (Zepbound)